PainReform Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
1.310
+0.005 (0.38%)
Oct 13, 2025, 1:20 PM EDT - Market open

PainReform Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-4.09-14.59-9.34-8.79-7.25-4.05
Upgrade
Depreciation & Amortization
0.190.020.020.020.01-
Upgrade
Stock-Based Compensation
0.510.310.81.731.220.24
Upgrade
Other Operating Activities
-0-0.020.22-0.09-2.13
Upgrade
Change in Accounts Payable
0.050.080.010.07-0.590.72
Upgrade
Change in Other Net Operating Assets
-2.621.581.620.60.05-1.59
Upgrade
Operating Cash Flow
-5.96-12.62-6.68-6.46-6.55-2.56
Upgrade
Capital Expenditures
-0-0.01-0.01-0.01-0.05-0.01
Upgrade
Investment in Securities
--6-6--
Upgrade
Investing Cash Flow
-0.05-0.015.99-6.01-0.05-0.01
Upgrade
Issuance of Common Stock
7.4410.15.55-7.9317.31
Upgrade
Other Financing Activities
-0.74-1.24-0.93--0.45-
Upgrade
Financing Cash Flow
6.78.864.62-7.4817.31
Upgrade
Foreign Exchange Rate Adjustments
0.010.010---
Upgrade
Net Cash Flow
0.7-3.773.93-12.470.8814.74
Upgrade
Free Cash Flow
-5.96-12.63-6.69-6.47-6.6-2.57
Upgrade
Free Cash Flow Per Share
-4.22-27.86-45.19-46.66-158.54-189.92
Upgrade
Levered Free Cash Flow
-4.54-7.21-3.56-3.12-3.9-2.76
Upgrade
Unlevered Free Cash Flow
-4.54-7.21-3.56-3.12-3.9-2.1
Upgrade
Change in Working Capital
-2.571.661.630.67-0.54-0.87
Upgrade
Updated Aug 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q